Identifying adherence barriers to oral endocrine therapy among breast cancer survivorsRutugandha Paranjpe, Susan Abughosh, Grace C. John et al.|Breast Cancer Research and Treatment|2018Cited by 99
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?Ekim Ekinci, Meghana V. Trivedi, Salima Nathoo et al.|Journal of Cancer Survivorship|2018Cited by 72
Neratinib in HER2-Positive Breast Cancer PatientsRutugandha Paranjpe, Meghana V. Trivedi, Dima Basatneh et al.|Annals of Pharmacotherapy|2019Cited by 30
Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic InstitutionGrace Hwang, Meghana V. Trivedi, Rutugandha Paranjpe et al.|Clinical Breast Cancer|2020Cited by 17
Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetesSoumya Chikermane, Michael L. Johnson, Manvi Sharma et al.|Breast Cancer Research and Treatment|2022Cited by 17